
CYTK Valuation
Cytokinetics Inc
- Overview
- Forecast
- Valuation
- Earnings
CYTK Relative Valuation
CYTK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CYTK is overvalued; if below, it's undervalued.
Historical Valuation
Cytokinetics Inc (CYTK) is now in the Fair zone, suggesting that its current forward PS ratio of 82.80 is considered Fairly compared with the five-year average of -9.84. The fair price of Cytokinetics Inc (CYTK) is between 35.71 to 196.95 according to relative valuation methord.
Relative Value
Fair Zone
35.71-196.95
Current Price:37.31
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-16.70
P/B
Median3y
-66.31
Median5y
-28.23
-9.00
FCF Yield
Median3y
-8.44
Median5y
-6.42
Competitors Valuation Multiple
The average P/S ratio for CYTK's competitors is 19.54, providing a benchmark for relative valuation. Cytokinetics Inc Corp (CYTK) exhibits a P/S ratio of 82.80, which is 323.69% above the industry average. Given its robust revenue growth of 89.10%, this premium appears sustainable.
People Also Watch

WFRD
Weatherford International PLC
57.900
USD
-0.82%

NUVL
Nuvalent Inc
82.080
USD
+1.99%

NE
Noble Corporation PLC
28.700
USD
+0.46%

INSP
Inspire Medical Systems Inc
128.640
USD
-2.21%

HXL
Hexcel Corp
62.360
USD
-0.38%

MAIN
Main Street Capital Corp
65.570
USD
+0.21%

NOVT
Novanta Inc
125.170
USD
-1.06%

VLY
Valley National Bancorp
9.530
USD
-1.75%

CRUS
Cirrus Logic Inc
100.300
USD
-2.56%

TKR
Timken Co
80.760
USD
-0.28%
FAQ

Is Cytokinetics Inc (CYTK) currently overvalued or undervalued?
Cytokinetics Inc (CYTK) is now in the Fair zone, suggesting that its current forward PS ratio of 82.80 is considered Fairly compared with the five-year average of -9.84. The fair price of Cytokinetics Inc (CYTK) is between 35.71 to 196.95 according to relative valuation methord.

What is Cytokinetics Inc (CYTK) fair value?

How does CYTK's valuation metrics compare to the industry average?

What is the current P/B ratio for Cytokinetics Inc (CYTK) as of Jul 25 2025?

What is the current FCF Yield for Cytokinetics Inc (CYTK) as of Jul 25 2025?

What is the current Forward P/E ratio for Cytokinetics Inc (CYTK) as of Jul 25 2025?
